The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Cabot Corp

NYSE: CBT
Last

(U.S.) $53.01

Today's change-0.63 -1.17%
Updated June 29 10:25 AM EDT. Delayed by at least 15 minutes.
 

Cabot Corp

NYSE: CBT
Last

(U.S.) $53.01

Today's change-0.63 -1.17%
Updated June 29 10:25 AM EDT. Delayed by at least 15 minutes.

Cabot Corp crosses below 20-day moving average

Cabot Corp is lower today, dropping (U.S.)$0.63 or 1.17% to (U.S.)$53.01 and crossing below its 20-day moving average. Over the last five days, shares have gained 1.61% and 4.89% year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $53.86
  • Previous close(U.S.) $53.64
  • High(U.S.) $53.86
  • Low(U.S.) $52.88
  • Bid / Ask(U.S.) $52.99 / (U.S.) $53.08
  • YTD % change+4.89%
  • Volume23,592
  • Average volume (10-day)538,940
  • Average volume (1-month)451,968
  • Average volume (3-month)373,279
  • 52-week range(U.S.) $43.43 to (U.S.) $61.34
  • Beta1.05
  • Trailing P/E14.21×
  • P/E 1 year forward15.47×
  • Forward PEG1.63×
  • Indicated annual dividend(U.S.) $1.26
  • Dividend yield2.38%
  • Trailing EPS(U.S.) $3.73
Updated June 29 10:25 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.77%

Based on its net profit margin of 9.77%, Cabot Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.71%Sector:Basic MaterialsIndustry:Chemicals - Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue678611619621
Total other revenue--------
Total revenue678611619621
Gross profit171194170161
Total cost of revenue507417449460
Total operating expense588529541538
Selling / general / administrative65577763
Research & development1471313
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)24822
Other operating expenses, total--------
Operating income90827883
Interest income (expense), net non-operating-13-13-14-13
Gain (loss) on sale of assets--------
Other--------
Income before tax78736674
Income after tax79565359
Income tax, total-1171315
Net income74545256
Total adjustments to net income--0-10
Net income before extra. items74545156
Minority interest-6-4-3-4
Equity in affiliates1211
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items74545056
Inc. avail. to common incl. extra. items74545156
Diluted net income74545156
Dilution adjustment----0--
Diluted weighted average shares63636363
Diluted EPS excluding extraordinary itemsvalue per share1.180.860.800.89
Dividends per sharevalue per share0.300.300.300.30
Diluted normalized EPSvalue per share1.201.450.830.92